Dexcom, Inc. Reports Preliminary Unaudited Revenue Guidance for the Fourth Quarter and Fiscal Year Ended December 31, 2021; Revenue Guidance for the Fiscal Year 2022
For the fiscal year 2021, the company expects the total preliminary, unaudited revenue to be approximately $2.448 billion, an increase of more than 27% over 2020.
For the fiscal year 2022, the company expects the revenue to be in the range of $2.82 billion to $2.94 billion. Representing expected growth of approximately 15% to 20% over 2021.